Molecular Warehouse selected for first cohort of the DigitalHealth.London Accelerator programme

The Accelerator sits within the DigitalHealth.London programme, which aims to accelerate the adoption of digital health solutions in the heart of the capital.

32 companies have been selected for the 2016-17 Accelerator programme cohort. 119 excellent companies initially competed for a place on the DigitalHealth.London Accelerator programme on the very first 2016/17 cohort, and a group of over 60 senior NHS, commercial and technical experts assessed each company’s business credibility and the likely benefit their innovations could deliver at a pan-London level.

DigitalHealth.London is a partnership, expert in accelerating the adoption of digital innovation by linking health and care organisations with digital health innovators for the benefit of patients and populations. It accelerates the adoption of digital innovations across health and care to improve patient and population outcomes and experience, and supports a sustainable future NHS.

DigitalHealth.London’s expert partnership is made up of London’s three Academic Health Science Networks (AHSNs) – Imperial College Health Partners, the Health Innovation Network and UCLPartners; MedCity; and NHS England.

For more information, please see

The Accelerator is part- funded by the European Regional Development Fund, as part of the European Structural and Investment Funds Growth Programme 2014-‐2020.

DigitalHealth.London Accelerator programme:
The DigitalHealth.London Accelerator is first programme of DigitalHealth.London. The programme is for digital health businesses that would benefit from better engagement with the NHS and the wider health sector, in order to refine and develop products and services that meet the needs of the system.

The year-long programme will be run over three consecutive years, and provides support to around 80 (20 – 30 in each year) small and medium sized businesses. The support, tailored to each business’s specific needs, focuses on engagement with clinicians and healthcare experts, refining products to meet needs, deepening understanding of the health system, showcasing in health facilities and developing business models in order to progress product development and access to the market.

For more information about the programme, please see

European Regional Development Fund:
The project is receiving funding from the England European Regional Development Fund as part of the European Structural and Investment Funds Growth Programme 2014-2020. The Department for Communities and Local Government (and in London the intermediate body Greater London Authority) is the Managing Authority for European Regional Development Fund. Established by the European Union, the European Regional Development Fund helps local areas stimulate their economic development by investing in projects, which will support innovation, businesses, create jobs and local community regenerations.

For more information visit